The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1396
August 6, 2012
View Complete Issue         Table of Contents 2019 
PSA Reconsidered
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
PSA Reconsidered
August 6, 2012 (Issue: 1396)
Three recent publications have focused attention once more on the contentious question of whether men should be screened for prostate cancer by measuring serum concentrations of prostate specific antigen (PSA).
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: PSA Reconsidered
Article code: 1396a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.